FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

332402005: Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3699591011 Cyproterone acetate 2 mg and ethinyl estradiol 35 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699593014 Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699594015 Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Is a Product containing cyproterone acetate and ethinyl estradiol false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cyproterone false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hormone false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. hormones et leurs métabolites et précurseurs false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethinylestradiol false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cyproterone acetate false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Estradiol false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Is a Product containing estradiol in oral dose form (medicinal product form) false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethinylestradiol false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Ethinylestradiol true Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cyproterone acetate false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Cyproterone acetate true Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Cyproterone acetate false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Ethinylestradiol false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has presentation strength numerator value 35 false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has presentation strength numerator value deux false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has presentation strength numerator value 0.035 false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has presentation strength numerator value deux false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Cyproterone acetate false Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Ethinylestradiol false Inferred relationship Some 2
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Is a Cyproterone- and ethinylestradiol-containing product in oral dose form false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Count of base of active ingredient deux false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Plays role Contraceptive therapeutic role (role) false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Plays role Antiacne therapeutic role (role) false Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet Is a Cyproterone and ethinylestradiol only product in oral dose form true Inferred relationship Some
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Ethinylestradiol true Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg true Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Cyproterone acetate true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start